Schedule 13G ownership disclosure

BIONTECH SE

Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) · CUSIP: 09075V102

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Medine GmbH

    Shares: 40,127,697.00 · Class: 16.7%

  • Prof. Ugur Sahin, M.D.

    Shares: 42,178,034.00 · Class: 17.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002056296-25-000003
Form type
SCHEDULE 13G/A
Filer
BioNTech SE
CIK
CIK 1776985
Filed
May 13, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub